Merck (MRK) Wins New KEYTRUDA Approvals As Tulisokibart Clears A Phase 3 Test

Merck (MRK) Wins New KEYTRUDA Approvals As Tulisokibart Clears A Phase 3 Test  Yahoo Finance

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.